Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Repligen Corporation - Common Stock (NQ:RGEN)

128.96 +2.26 (+1.78%)
Streaming Delayed Price Updated: 2:20 PM EDT, Jun 6, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 303,808
Open 127.80
Bid (Size) 128.80 (1)
Ask (Size) 129.05 (1)
Prev. Close 126.70
Today's Range 127.80 - 130.68
52wk Range 102.97 - 182.52
Shares Outstanding 55,679,964
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Winners And Losers Of Q1: Repligen (NASDAQ:RGEN) Vs The Rest Of The Drug Development Inputs & Services Stocks
Let’s dig into the relative performance of Repligen (NASDAQ:RGEN) and its peers as we unravel the now-completed Q1 drug development inputs & services earnings season. 
Via StockStory
Drug Development Inputs & Services Stocks Q1 In Review: Repligen (NASDAQ:RGEN) Vs Peers
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Repligen (NASDAQ:RGEN) and the best and... 
Via StockStory

Performance

YTD
-9.8%
-9.8%
1 Month
-1.1%
-1.1%
3 Month
-19.5%
-19.5%
6 Month
-9.3%
-9.3%
1 Year
-14.4%
-14.4%

More News

Read More
3 of Wall Street’s Favorite Stocks in Hot Water
Via StockStory
Repligen, Bruker, Agilent, Medpace, and Revvity Shares Skyrocket, What You Need To Know
Via StockStory
Topics Government Stocks World Trade
Exposures Political Tariff US Equities
Earnings Scheduled For April 29, 2025
Via Benzinga
The Analyst Verdict: Repligen In The Eyes Of 4 Experts
Via Benzinga
Earnings Scheduled For February 20, 2025
Via Benzinga
1 High-Flying Stock with Exciting Potential and 2 to Keep Off Your Radar
Via StockStory
Deep Dive Into Repligen Stock: Analyst Perspectives (8 Ratings)
Via Benzinga
RGEN Q1 Earnings Call: Repligen Delivers Above-Consensus Revenue, Raises Sales Outlook Amid Tariff Uncertainty
Via StockStory
Topics World Trade
Exposures Tariff
Repligen (NASDAQ:RGEN) Posts Better-Than-Expected Sales In Q1, Full-Year Outlook Slightly Exceeds Expectations
Via StockStory
Topics World Trade
Exposures Tariff
Repligen (RGEN) Q1 Earnings: What To Expect
Via StockStory
Topics World Trade
Exposures Tariff
3 Healthcare Stocks That Concern Us
Via StockStory
Topics Stocks
Exposures COVID-19 US Equities
Repligen (RGEN): Buy, Sell, or Hold Post Q4 Earnings?
Via StockStory
Topics Stocks
Exposures US Equities
Winners And Losers Of Q4: IQVIA (NYSE:IQV) Vs The Rest Of The Drug Development Inputs & Services Stocks
Via StockStory
Drug Development Inputs & Services Stocks Q4 In Review: Medpace (NASDAQ:MEDP) Vs Peers
Via StockStory
Demystifying Repligen: Insights From 6 Analyst Reviews
Via Benzinga
Q4 Rundown: PacBio (NASDAQ:PACB) Vs Other Life Sciences Tools & Services Stocks
Via StockStory
Topics Artificial Intelligence
Exposures Artificial Intelligence
Q4 Earnings Recap: Azenta (NASDAQ:AZTA) Tops Drug Development Inputs & Services Stocks
Via StockStory
A Look Back at Drug Development Inputs & Services Stocks’ Q4 Earnings: Repligen (NASDAQ:RGEN) Vs The Rest Of The Pack
Via StockStory
3 Small-Cap Stocks Skating on Thin Ice
Via StockStory
908 Devices Strategic Shift: Desktop Sale To Repligen Optimizes Future Growth
Via Benzinga
Repligen Q4 Earnings Momentum Highlights Market Growth, Issues Strong 2025 Outlook
Via Benzinga
Repligen's Q4 Slightly Tops Expectations
Via The Motley Fool
Repligen (NASDAQ:RGEN) Posts Q4 Sales In Line With Estimates
Via StockStory
Exposures COVID-19

Frequently Asked Questions

Is Repligen Corporation - Common Stock publicly traded?
Yes, Repligen Corporation - Common Stock is publicly traded.
What exchange does Repligen Corporation - Common Stock trade on?
Repligen Corporation - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Repligen Corporation - Common Stock?
The ticker symbol for Repligen Corporation - Common Stock is RGEN on the Nasdaq Stock Market
What is the current price of Repligen Corporation - Common Stock?
The current price of Repligen Corporation - Common Stock is 128.96
When was Repligen Corporation - Common Stock last traded?
The last trade of Repligen Corporation - Common Stock was at 06/06/25 02:20 PM ET
What is the market capitalization of Repligen Corporation - Common Stock?
The market capitalization of Repligen Corporation - Common Stock is 7.18B
How many shares of Repligen Corporation - Common Stock are outstanding?
Repligen Corporation - Common Stock has 7B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.